Shares of PetVivo Holdings, Inc. (NASDAQ:PETV – Get Free Report) fell 5% on Monday . The stock traded as low as $0.7013 and last traded at $0.76. Approximately 9,822 shares changed hands during trading, a decline of 9% from the average session volume of 10,788 shares. The stock had previously closed at $0.80.
PetVivo Trading Down 3.7%
The business has a 50 day simple moving average of $0.79 and a 200-day simple moving average of $0.83. The stock has a market capitalization of $27.82 million, a price-to-earnings ratio of -1.64 and a beta of 1.23. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.42 and a quick ratio of 0.47.
About PetVivo
PetVivo, Inc, headquartered in Ormond Beach, Florida, is a regenerative biomedical technology company specializing in veterinary applications. The company’s core focus is on developing and commercializing sustained-release intra-articular therapies for animals through its proprietary RediVet injectable micro-plug system. This biodegradable polymer platform is designed to provide controlled release of therapeutic agents directly into joints, targeting osteoarthritis and related inflammatory conditions in companion and performance animals.
PetVivo’s lead product, the RediVet-40 system, has been evaluated in proof-of-concept trials involving canine patients with osteoarthritis.
Read More
- Five stocks we like better than PetVivo
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
